FS
Simonetta, Federico
Affiliation entities
Research groups
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation : a case report | Frontiers in immunology | 2024 | 12 | 10 | |||
Molecular imaging of acute graft-versus-host disease | The Journal of nuclear medicine | 2024 | 31 | 4 | |||
Circadian tumor infiltration and function of CD8+ T cells dictate immunotherapy efficacy | Cell | 2024 | 352 | 80 | |||
Severe anaphylaxis after chimeric antigen receptor T-cell injection : a case report | EJHaem | 2024 | 20 | 2 | |||
Granulocyte-Macrophage Colony-Stimulating Factor in Allogenic Hematopoietic Stem Cell Transplantation : From Graft-versus-Host Disease to the Graft-versus-Tumor Effect | Transplantation and cellular therapy | 2024 | 32 | 11 | |||
Id3 keeps the PD-1 checkpoint in check in GVHD | Blood | 2024 | 26 | 0 | |||
Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies : basic considerations and best practice recommendations from the EBMT | The lancet. Haematology | 2024 | 22 | 0 | |||
How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma? | Hematological oncology | 2024 | 66 | 0 | |||
Single-cell transcriptomics reveal different maturation stages and sublineage commitment of human thymic invariant natural killer T cells | Journal of leukocyte biology | 2024 | 39 | 14 | |||
Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3) | The journal of infectious diseases | 2024 | 31 | 2 | |||
NK and T cell repertoire is established early after allogeneic HSCT and is profoundly imprinted by CMV reactivation | Blood advances | 2024 | 31 | 22 | |||
Selective haematological cancer eradication with preserved haematopoiesis | Nature | 2024 | 42 | 7 | |||
Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study | Frontiers in immunology | 2023 | 26 | 8 | |||
Prevention of acute GVHD using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T cells in vivo | Blood | 2023 | 14 | 2 | |||
Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption | Frontiers in oncology | 2023 | 25 | 7 | |||
CMV serostatus and T-cell repertoire diversity 5 years after allogeneic hematopoietic stem cell transplantation | Leukemia & lymphoma | 2023 | 18 | 10 | |||
Clinical prediction model for prognosis in kidney transplant recipients (KIDMO) : study protocol | Diagnostic and prognostic research | 2023 | 13 | 6 | |||
Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia | Leukemia | 2023 | 27 | 1 | |||
Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients Plasma | Viruses | 2023 | 97 | 52 | |||
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2) | Open forum infectious diseases | 2023 | 18 | 10 | |||
Multimodal Immunomonitoring of Hematopoietic Stem Cell Transplantation and Cellular Therapies for Hematological Malignancies | 2023 | 53 | 132 | ||||
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2) | Open forum infectious diseases | 2023 | 16 | 9 | |||
The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation – Data from the Swiss transplant cohort study | Frontiers in immunology | 2022 | 112 | 28 | |||
An epigenetic signature in CD19-CAR T cells predicts clinical outcome | Trends in cancer | 2022 | 134 | 0 | |||
Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantation | Frontiers in immunology | 2022 | 53 | 20 | |||
Analysis of T cell Repertoire and Transcriptome Identifies Mechanisms of Regulatory T cell (Treg) Suppression of GvHD | Blood | 2022 | 297 | 39 | |||
A National Survey Comparing Patients' and Transplant Professionals' Research Priorities in the Swiss Transplant Cohort Study | Transplant international | 2022 | 85 | 51 | |||
Use of statins after liver transplantation is associated with improved survival: results of a nationwide study | Alimentary pharmacology & therapeutics | 2022 | 64 | 37 | |||
IL-2 receptor engineering enhances regulatory T cell function suppressed by calcineurin inhibitor | American journal of transplantation | 2022 | 13 | 1 | |||
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation : A Retrospective Study | Transplantation and cellular therapy | 2022 | 73 | 35 | |||
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | 2022 | 153 | 45 | |||
ICOS immunoPET enables visualization of activated T cells and early diagnosis of murine acute gastrointestinal GvHD | Blood advances | 2022 | 124 | 116 | |||
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia | Leukemia | 2022 | 17 | 6 | |||
T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients | Annals of oncology | 2022 | 97 | 29 | |||
Multiparameter longitudinal imaging of immune cell activity in chimeric antigen receptor T cell and checkpoint blockade therapies | ACS central science | 2022 | 15 | 8 | |||
Dual cytokine blockade in acute GVHD | Blood | 2021 | 146 | 1 | |||
The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft | Bone marrow transplantation | 2021 | 249 | 0 | |||
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation | Frontiers in immunology | 2021 | 100 | 61 | |||
Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-Priming | Clinical cancer research | 2021 | 146 | 58 | |||
Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET | Clinical cancer research | 2021 | 110 | 41 | |||
Imaging alloreactive T cells provides early warning of organ transplant rejection | JCI insight | 2021 | 154 | 65 | |||
Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance | The journal of clinical investigation | 2021 | 124 | 37 | |||
Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients | Bone marrow transplantation | 2021 | 208 | 2 | |||
Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects | Blood | 2021 | 89 | 1 | |||
Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018 | Antimicrobial resistance and infection control | 2021 | 245 | 53 | |||
Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD | Blood advances | 2021 | 93 | 95 | |||
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients | Medical mycology | 2021 | 239 | 1 | |||
AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia | Cancers | 2021 | 130 | 50 | |||
Suivi immunologique des patients traités par cellules CAR-T pour hémopathie maligne: recommandations du groupe CARTi et de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) | Bulletin du cancer | 2021 | 86 | 46 | |||
Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion | Frontiers in Immunology | 2020 | 207 | 100 | |||
Viral Delivery of CAR Targets to Solid Tumors Enables Effective Cell Therapy | Molecular Therapy Oncolytics | 2020 | 179 | 107 | |||
Torque Teno Virus as a potential biomarker for complications and survival after allogeneic hematopoietic stem cell transplantation | Frontiers in Immunology | 2020 | 457 | 120 | |||
MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors | JCI Insight | 2020 | 113 | 0 | |||
Visualization of activated T cells by OX40-immunoPET as a strategy for diagnosis of acute Graft-versus-Host-Disease | Cancer Research | 2020 | 138 | 110 | |||
Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease | Frontiers in Immunology | 2019 | 205 | 162 | |||
Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway | JCI Insight | 2019 | 205 | 128 | |||
Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Immunology | 2019 | 282 | 113 | |||
Engineered immune cells as highly sensitive cancer diagnostics | Nature Biotechnology | 2019 | 182 | 1 | |||
A rare case of immune thrombocytopenia secondary to breast cancer | Clinical Case Reports | 2019 | 261 | 86 | |||
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation | Leukemia and Lymphoma | 2018 | 475 | 2 | |||
Central nervous system graft-versus-host disease (CNS-GvHD) after allogeneic haematopoietic stem cell transplantation | BMJ Case Reports | 2018 | 379 | 1 | |||
Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome | Bone Marrow Transplantation | 2018 | 382 | 0 | |||
Human pegivirus persistence in the human blood virome after allogeneic haematopoietic stem cell transplantation | Clinical Microbiology and Infection | 2018 | 1 306 | 331 | |||
Successful treatment of refractory lupus nephritis by the sequential use of rituximab and belimumab | Joint bone spine | 2017 | 596 | 1 | |||
Torque Teno Virus Load and Acute Rejection after Orthotopic Liver Transplantation | Transplantation | 2017 | 692 | 0 | |||
Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation | Frontiers in Immunology | 2017 | 194 | 110 | |||
Syndrome hémophagocytaire réactionnel | Revue médicale suisse | 2017 | 457 | 235 | |||
Reversible encephalopathy with photoparoxysmal response during imipenem/cilastatin treatment | Journal of the Neurological Sciences | 2016 | 310 | 0 | |||
Modulation of T-bet and Eomes during Maturation of Peripheral Blood NK Cells Does Not Depend on Licensing/Educating KIR | Frontiers in immunology | 2016 | 504 | 191 | |||
Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants | Bone marrow transplantation | 2016 | 612 | 4 | |||
Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Immunology | 2016 | 441 | 208 | |||
Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies | Bone marrow transplantation | 2016 | 454 | 2 | |||
T-bet and Eomesodermin in NK Cell Development, Maturation, and Function | Frontiers in immunology | 2016 | 498 | 237 | |||
Complete and sustained remission of spondyloarthritis after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome | Joint bone spine | 2015 | 553 | 2 | |||
Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab | Annals of hematology | 2015 | 546 | 2 | |||
NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin | The Journal of immunology | 2015 | 510 | 3 | |||
High eomesodermin expression among CD57+ CD8+ T cells identifies a CD8+ T cell subset associated with viral control during chronic human immunodeficiency virus infection | Journal of virology | 2014 | 469 | 0 |